PER-032-02已完成未知
PHASE III STUDY OF PEG-INTRON IN PATIENTS INFECTED BY HIV WHO HAVE EXPERIENCED MULTIPLE TREATMENTS
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •HIV positive; history of virological failure in at least 2 antiretroviral regimens including exposure to at least one nudeoside reverse transcriptase inhibitor, a non-nudeide reverse transcriptase inhibitor, and a protease inhibitor; > 400 and <50,000 copies / mL of HIV RNA at the time of entering the study with optimized antimetroviral therapy prior to initiation 2-6 months before incorporation; laboratory parameters; platelet count> 75,000 u / L, hemoglobin> 9 gm / dL, absolute neutrophil count> 1000 / uL.
排除标准
- •Current treatment with ribavirin; Subjects with a diagnosis or history of moderate or severe depression that requires current psychiatric intervention.
- •Women of childbearing age who are breastfeeding, pregnant or not use adequate contraception; concomitant use of immunosuppressants or cytotoxic agents; a history of seizures that require the use of anticonvulsants.
研究者
相似试验
进行中（未招募）
1 期
A Study to Assess Treatment with PEG-Intron® and Rebetol® in Naïve Patients with Genotype 1 Chronic Hepatitis C and Slow Virological Response - Slow responder studyChronic Hepatitis C, Genotype 1EUCTR2004-000488-83-ESIntergrated Therapeutics Group, Incorporated-a subsidiary of Schering Plough1,200
进行中（未招募）
不适用
A Study to Assess Treatment with PEG-Intron® and Rebetol® in Naïve Patients with Genotype 1 Chronic Hepatitis C and Slow Virological Response - Slow responder studyEUCTR2004-000488-83-HUIntegrated Therapeutics Group, Incorporated-a subsidiary of Schering Plough1,200
进行中（未招募）
1 期
A Study to Assess Treatment with PEG-Intron® and Rebetol® in Naïve Patients with Genotype 1 Chronic Hepatitis C and Slow Virological Response - Slow responder studyEUCTR2004-000488-83-GBSchering Plough Research Institute, a Division of Schering Corporation1,200
进行中（未招募）
不适用
A Study to Assess Treatment with PEG-Intron® and Rebetol® in Naïve Patients with Genotype 1 Chronic Hepatitis C and Slow Virological Response - Slow responder studyChronic Hepatitis C, Genotype 1EUCTR2004-000488-83-CZIntergrated Therapeutics Group, Incorporated-a subsidiary of Schering Plough1,200
进行中（未招募）
不适用
A Study to Assess Treatment with PEG-Intron® and Rebetol® in Naïve Patients with Genotype 1 Chronic Hepatitis C and Slow Virological Response - Slow responder studyChronic Hepatitis C, Genotype 1EUCTR2004-000488-83-ATIntegrated Therapeutics Group, Incorporated-a subsidiary of Schering Plough1,200